Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Izotropic Corporation (IZOZF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.28500.0000 (0.00%)
At close: 03:19PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.2850
Open0.2965
BidN/A x N/A
AskN/A x N/A
Day's Range0.2835 - 0.2965
52 Week Range0.1930 - 0.6380
Volume8,975
Avg. Volume35,029
Market Cap14.908M
Beta (5Y Monthly)2.76
PE Ratio (TTM)N/A
EPS (TTM)-0.0700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for IZOZF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IZOTROPIC CORPORATION
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, railroads may be in for a bumpy ride; ESG has some opportunities; biotechs innovate; and Constellation Brands, Autodesk, and Tencent.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
  • Newsfile

    Izotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology

    Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, releases statements from select key members of its technical and scientific teams advocating for the commercialization and clinical capabilities of breast CT techno

  • Newsfile

    Izotropic Releases First Video of IzoView

    Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, is pleased to release the first video showcasing the completed engineering of IzoView. This video is the first in a series of presentations, interviews, and demonstra

  • Newsfile

    Izotropic Reports Board Meeting Results

    Vancouver, British Columbia--(Newsfile Corp. - January 4, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, reports the results of the board meeting held December 29, 2022. The Board of Directors is pleased to report the strengthening and refocussing of Izotropic's manageme

Advertisement
Advertisement